
China’s National Medical Products Administration issued a notice on November 9, 2026, introducing a three-tier management system for changes to special cosmetics. From November 20, 2026, applications for such changes will be managed according to their classification, with requirements and compliance pathways set for each tier.
The change is intended to streamline approval processes while strengthening oversight after products reach the market. For companies handling special cosmetics, its immediate significance is that the route for a proposed change will depend on how that change is classified.

A three-tier system creates a framework for distinguishing among changes rather than treating every application as a single type of request. In practice, the classification assigned to a proposed change will be important because each tier has its own management requirements and compliance pathway.
The practical effect on any particular application will depend on the criteria used to place it in a tier and the requirements attached to that tier. The announcement establishes the direction of the change, but it does not describe those criteria or set out the individual procedures in the information available here.
The most direct implications are likely to arise when a company plans a change and prepares its application. Before choosing a compliance pathway, the company will need to understand which tier applies. That assessment could affect how the application is organized and how the proposed change is scheduled.
Regulatory teams may also need to coordinate with colleagues responsible for the proposed change so that its scope is clear before the application route is selected. The significance of that coordination will depend on the details of the final requirements and the nature of the change.
The notice also links the new approach to post-market oversight. This suggests that the classification of changes should be considered in the context of managing products after they have reached the market, as well as preparing applications. The available announcement does not specify how oversight will operate for each tier.
Businesses following the rollout will have reason to look for regulatory information explaining how changes are classified, what each pathway requires and how the system applies from November 20. Those details will determine how much the new framework changes the work involved in individual applications.
The stated goal of streamlining approval does not by itself establish that every change will be processed more quickly or require less work. The outcome for a particular application will depend on its classification and the applicable requirements.
Related Intelligence